Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1

PLoS Pathogens

Volumn 5, Issue 6, 2009, Pages

  Aras, Siddhesh ^a   Singh, Gyanendra ^a   Johnston, Kenneth ^a   Foster, Timothy ^a,b   Aiyar, Ashok ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; ZINC; ZINC BINDING PROTEIN; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; MENADIONE;

ARTICLE; CELL HYPOXIA; CELL SURVIVAL; DIMERIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MOLECULAR SENSOR; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN TENSION; TRANSACTIVATION; TRANSCRIPTION INITIATION; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; DRUG EFFECT; EPSTEIN BARR VIRUS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; STATISTICAL ANALYSIS; TUMOR CELL LINE;

HUMAN HERPESVIRUS 4;

AMINO ACID SEQUENCE; CELL HYPOXIA; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; DATA INTERPRETATION, STATISTICAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ACTIVATION; VITAMIN K 3; ZINC;

EID: 67650901947     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000469     Document Type: Article

References (109)

1. Humme S, Reisbach G, Feederle R, Delecluse HJ, Bousset K, et al. (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100: 10989-10994. (Pubitemid 37140140)
2. Altmann M, Pich D, Ruiss R, Wang J, Sugden B, et al. (2006) Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci U S A 103: 14188-14193. (Pubitemid 44453001)
3. Hebner C, Lasanen J, Battle S, Aiyar A (2003) The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenance. Virology 311: 263-274. (Pubitemid 36814058)
4. Day L, Chau CM, Nebozhyn M, Rennekamp AJ, Showe M, et al. (2007) Chromatin profiling of Epstein-Barr virus latency control region. J Virol 81: 6389-6401. (Pubitemid 46878045)
5. Sears J, Ujihara M, Wong S, Ott C, Middeldorp J, et al. (2004) The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J Virol 78: 11487-11505. (Pubitemid 39390736)
6. Sears J, Kolman J, Wahl GM, Aiyar A (2003) Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1. J Virol 77: 11767-11780. (Pubitemid 37271674)
7. Hung SC, Kang MS, Kieff E (2001) Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc Natl Acad Sci U S A 98: 1865-1870.
8. Yie J, Merika M, Munshi N, Chen G, Thanos D (1999) The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. Embo J 18: 3074-3089. (Pubitemid 29255616)
9. Kim TK, Maniatis T (1997) The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. Mol Cell 1: 119-129.
10. Kennedy G, Sugden B (2003) EBNA-1, a bifunctional transcriptional activator. Mol Cell Biol 23: 6901-6908.
11. Gahn TA, Sugden B (1995) An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 69: 2633-2636.
12. Sugden B, Warren N (1989) A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 63: 2644-2649. (Pubitemid 19137542)
13. Puglielli MT, Woisetschlaeger M, Speck SH (1996) oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 70: 5758-5768. (Pubitemid 26266783)
14. Langle-Rouault F, Patzel V, Benavente A, Taillez M, Silvestre N, et al. (1998) Up to 100-fold increase of apparent gene expression in the presence of Epstein- Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J Virol 72: 6181-6185. (Pubitemid 28283412)
15. Krishna SS, Majumdar I, Grishin NV (2003) Structural classification of zinc fingers: survey and summary. Nucleic Acids Res 31: 532-550.
16. Mackey D, Middleton T, Sugden B (1995) Multiple regions within EBNA1 can link DNAs. J Virol 69: 6199-6208.
17. Meetei AR, Ullas KS, Rao MR (2000) Identification of two novel zinc finger modules and nuclear localization signal in rat spermatidal protein TP2 by site-directed mutagenesis. J Biol Chem 275: 38500-38507.
18. Schiff LA, Nibert ML, Fields BN (1988) Characterization of a zinc blotting technique: evidence that a retroviral gag protein binds zinc. Proc Natl Acad Sci U S A 85: 4195-4199.
19. McIntyre MC, Frattini MG, Grossman SR, Laimins LA (1993) Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J Virol 67: 3142-3150.
20. Makhov P, Golovine K, Uzzo RG, Rothman J, Crispen PL, et al. (2008) Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Cell Death Differ 15: 1745-1751.
21. Meplan C, Richard MJ, Hainaut P (2000) Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19: 5227-5236.
22. Xiao Z, Ehrlich E, Luo K, Xiong Y, Yu XF (2007) Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. Faseb J 21: 217-222. (Pubitemid 46052559)
23. Triezenberg SJ, Kingsbury RC, McKnight SL (1988) Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev 2: 718-729.
24. Tasset D, Tora L, Fromental C, Scheer E, Chambon P (1990) Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62: 1177-1187. (Pubitemid 20333777)
25. Min S, Crider-Miller SJ, Taparowsky EJ (1994) The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation. Cell Growth Differ 5: 563-573. (Pubitemid 24252321)
26. Kirchmaier AL, Sugden B (1997) Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J Virol 71: 1766-1775. (Pubitemid 27078552)
27. Thanos D, Maniatis T (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100. (Pubitemid 26007801)
28. Bagga R, Michalowski S, Sabnis R, Griffith JD, Emerson BM (2000) HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology. Nucleic Acids Res 28: 2541-2550. (Pubitemid 30420852)
29. McCarty AS, Kleiger G, Eisenberg D, Smale ST (2003) Selective dimerization of a C2H2 zinc finger subfamily. Mol Cell 11: 459-470. (Pubitemid 36297056)
30. Stenger JE, Tegtmeyer P, Mayr GA, Reed M, Wang Y, et al. (1994) p53 oligomerization and DNA looping are linked with transcriptional activation. Embo J 13: 6011-6020.
31. Frappier L, O'Donnell M (1991) Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A 88: 10875-10879. (Pubitemid 21915941)
32. Su W, Middleton T, Sugden B, Echols H (1991) DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc Natl Acad Sci U S A 88: 10870-10874. (Pubitemid 21915940)
33. Middleton T, Sugden B (1992) EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol 66: 489-495.
34. Laine A, Frappier L (1995) Identification of Epstein-Barr virus nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound proteins. J Biol Chem 270: 30914-30918. (Pubitemid 26012174)
35. Hu CD, Grinberg AV, Kerppola TK (2006) Visualization of protein interactions in living cells using bimolecular fluorescence complementation (BiFC) analysis. Curr Protoc Cell Biol Chapter 21: Unit 21 23.
36. Sun Y, Bian J, Wang Y, Jacobs C (1997) Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound. Oncogene 14: 385-393. (Pubitemid 27087101)
37. You JS, Wang M, Lee SH (2000) Functional characterization of zinc-finger motif in redox regulation of RPA-ssDNA interaction. Biochemistry 39: 12953-12958. (Pubitemid 30825898)
38. Marmorstein R, Carey M, Ptashne M, Harrison SC (1992) DNA recognition by GAL4: structure of a protein-DNA complex. Nature 356: 408-414.
39. Barlow PN, Luisi B, Milner A, Elliott M, Everett R (1994) Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J Mol Biol 237: 201-211. (Pubitemid 2050630)
40. Wang Y, Finan JE, Middeldorp JM, Hayward SD (1997) P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology 236: 18-29. (Pubitemid 27411469)
41. Kim AL, Maher M, Hayman JB, Ozer J, Zerby D, et al. (1997) An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha. Virology 239: 340-351. (Pubitemid 28105640)
42. Shire K, Ceccarelli DF, Avolio-Hunter TM, Frappier L (1999) EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol 73: 2587-2595. (Pubitemid 29135642)
43. Lin A, Wang S, Nguyen T, Shire K, Frappier L (2008) The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J Virol 82: 12009-12019.
44. Wysokenski DA, Yates JL (1989) Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol 63: 2657-2666.
45. Huang RP, Adamson ED (1993) Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol 12: 265-273.
46. Mitomo K, Nakayama K, Fujimoto K, Sun X, Seki S, et al. (1994) Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 145: 197-203. (Pubitemid 24261434)
47. Yao KS, Xanthoudakis S, Curran T, O'Dwyer PJ (1994) Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 14: 5997-6003. (Pubitemid 24264428)
48. Xanthoudakis S, Curran T (1992) Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. Embo J 11: 653-665.
49. Gaiddon C, Moorthy NC, Prives C (1999) Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. Embo J 18: 5609-5621. (Pubitemid 29486380)
50. Hutchison KA, Matic G, Meshinchi S, Bresnick EH, Pratt WB (1991) Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor. J Biol Chem 266: 10505-10509. (Pubitemid 21906831)
51. Knoepfel L, Steinkuhler C, Carri MT, Rotilio G (1994) Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor Sp1. Biochem Biophys Res Commun 201: 871-877. (Pubitemid 24206952)
52. Liang X, Lu B, Scott GK, Chang CH, Baldwin MA, et al. (1998) Oxidant stress impaired DNA-binding of estrogen receptor from human breast cancer. Mol Cell Endocrinol 146: 151-161. (Pubitemid 29003290)
53. Webster KA, Prentice H, Bishopric NH (2001) Oxidation of zinc finger transcription factors: physiological consequences. Antioxid Redox Signal 3: 535-548. (Pubitemid 32785979)
54. Whittal RM, Benz CC, Scott G, Semyonov J, Burlingame AL, et al. (2000) Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding. Biochemistry 39: 8406-8417. (Pubitemid 30489937)
55. Wan L, Ottinger E, Cho S, Dreyfuss G (2008) Inactivation of the SMN complex by oxidative stress. Mol Cell 31: 244-254. (Pubitemid 352001393)
56. Laux I, Nel A (2001) Evidence that oxidative stress-induced apoptosis by menadione involves Fas-dependent and Fas-independent pathways. Clin Immunol 101: 335-344. (Pubitemid 33145017)
57. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, et al. (1997) AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638. (Pubitemid 27180424)
58. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, et al. (1999) Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274: 35809-35815. (Pubitemid 129512885)
59. Krieger JA, Landsiedel JC, Lawrence DA (1996) Differential in vitro effects of physiological and atmospheric oxygen tension on normal human peripheral blood mononuclear cell proliferation, cytokine and immunoglobulin production. Int J Immunopharmacol 18: 545-552.
60. Dardzinski BJ, Sotak CH (1994) Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 32: 88-97.
61. Star-Lack JM, Adalsteinsson E, Adam MF, Terris DJ, Pinto HA, et al. (2000) In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol 21: 183-193.
62. Tierney RJ, Steven N, Young LS, Rickinson AB (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68: 7374-7385. (Pubitemid 24328793)
63. Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, et al. (2004) Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101: 239-244. (Pubitemid 38084234)
64. Chau CM, Lieberman PM (2004) Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 78: 12308-12319.
65. Fejer G, Koroknai A, Banati F, Gyory I, Salamon D, et al. (2008) Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. J Gen Virol 89: 1364-1370.
66. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT (2000) Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol 165: 1013-1021.
67. Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, et al. (1998) Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A 95: 8298-8303. (Pubitemid 28326107)
68. Pan Y, Oprysko PR, Asham AM, Koch CJ, Simon MC (2004) p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23: 4975-4983. (Pubitemid 38938730)
69. Davenport MG, Pagano JS (1999) Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol 73: 3154-3161.
70. Grasser FA, Haiss P, Gottel S, Mueller-Lantzsch N (1991) Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. J Virol 65: 3779-3788.
71. Pandya J, Walling DM (2004) Epstein-Barr virus latent membrane protein 1 (LMP-1) half-life in epithelial cells is down-regulated by lytic LMP-1. J Virol 78: 8404-8410. (Pubitemid 38944325)
72. Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, et al. (1990) Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. J Virol 64: 2126-2134. (Pubitemid 20148457)
73. Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E (1990) Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 64: 3407-3416. (Pubitemid 20219546)
74. Kim PW, Sun ZY, Blacklow SC, Wagner G, Eck MJ (2003) A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8. Science 301: 1725-1728. (Pubitemid 37174366)
75. Aiyar A, Tyree C, Sugden B (1998) The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. Embo J 17: 6394-6403. (Pubitemid 28497811)
76. Singh G, Aras S, Zea AH, Koochekpour S, Aiyar A (2009) Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains. J Virol 83: 4227-4235.
77. Frankel AD, Bredt DS, Pabo CO (1988) Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240: 70-73. (Pubitemid 18101475)
78. Keys JR, Tallack MR, Zhan Y, Papathanasiou P, Goodnow CC, et al. (2008) A mechanism for Ikaros regulation of human globin gene switching. Br JHaematol 141: 398-406.
79. Antson AA, Burns JE, Moroz OV, Scott DJ, Sanders CM, et al. (2000) Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 403: 805-809. (Pubitemid 30111845)
80. Hernandez-Ramon EE, Burns JE, Zhang W, Walker HF, Allen S, et al. (2008) Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region. J Virol 82: 4853-4861. (Pubitemid 351657047)
81. Prasad AS (2008) Zinc in human health: effect of zinc on immune cells. Mol Med 14: 353-357. (Pubitemid 351785709)
82. Hirano T, Murakami M, Fukada T, Nishida K, Yamasaki S, et al. (2008) Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv Immunol 97: 149-176. (Pubitemid 351697819)
83. Sekler I, Sensi SL, Hershfinkel M, Silverman WF (2007) Mechanism and regulation of cellular zinc transport. Mol Med 13: 337-343. (Pubitemid 47378133)
84. Lazarczyk M, Favre M (2008) The role of Zn2+ ions in host-virus interactions. J Virol 82: 11486-11494.
85. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, et al. (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205: 35-42. (Pubitemid 351185713)
86. Li Y, Kimura T, Laity JH, Andrews GK (2006) The zinc-sensing mechanism of mouse MTF-1 involves linker peptides between the zinc fingers. Mol Cell Biol 26: 5580-5587. (Pubitemid 44134316)
87. Andrews GK (2001) Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals 14: 223-237.
88. Moreno MA, Ibrahim-Granet O, Vicentefranqueira R, Amich J, Ave P, et al. (2007) The regulation of zinc homeostasis by the ZafA transcriptional activator is essential for Aspergillus fumigatus virulence. Mol Microbiol 64: 1182-1197. (Pubitemid 46849011)
89. Bird AJ, Zhao H, Luo H, Jensen LT, Srinivasan C, et al. (2000) A dual role for zinc fingers in both DNA binding and zinc sensing by the Zap1 transcriptional activator. Embo J 19: 3704-3713. (Pubitemid 30462128)
90. Hayashi S, Hajiro-Nakanishi K, Makino Y, Eguchi H, Yodoi J, et al. (1997) Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res 25: 4035-4040. (Pubitemid 27443331)
91. Rong Y, Hu F, Huang R, Mackman N, Horowitz JM, et al. (2006) Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res 66: 7067-7074. (Pubitemid 44197683)
92. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, et al. (1999) Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274: 10363-10371. (Pubitemid 129518330)
93. Mishell RI, Dutton RW (1967) Immunization of dissociated spleen cell cultures from normal mice. J Exp Med 126: 423-442.
94. Naldini A, Carraro F, Silvestri S, Bocci V (1997) Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells. J Cell Physiol 173: 335-342. (Pubitemid 27481090)
95. Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, et al. (1995) B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. Embo J 14: 88-96.
96. Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseno C, et al. (2005) Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24: 1711-1717. (Pubitemid 40461127)
97. Sandberg ML, Kaykas A, Sugden B (2000) Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression. J Virol 74: 9755-9761. (Pubitemid 30746829)
98. Lam N, Sugden B (2003) LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. Embo J 22: 3027-3038. (Pubitemid 36758623)
99. Lam N, Sandberg ML, Sugden B (2004) High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells. J Virol 78: 1657-1664. (Pubitemid 38176698)
100. Kilger E, Kieser A, Baumann M, Hammerschmidt W (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. Embo J 17: 1700-1709. (Pubitemid 28119123)
101. Partridge JD, Scott C, Tang Y, Poole RK, Green J (2006) Escherichia coli transcriptome dynamics during the transition from anaerobic to aerobic conditions. J Biol Chem 281: 27806-27815. (Pubitemid 44414493)
102. Sahaf B, Atkuri K, Heydari K, Malipatlolla M, Rappaport J, et al. (2008) Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease. Proc Natl Acad Sci U S A 105: 5111-5116. (Pubitemid 351738518)
103. Sanders CM, Sizov D, Seavers PR, Ortiz-Lombardia M, Antson AA (2007) Transcription activator structure reveals redox control of a replication initiation reaction. Nucleic Acids Res 35: 3504-3515. (Pubitemid 47073610)
104. Wang P, Day L, Dheekollu J, Lieberman PM (2005) A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. J Virol 79: 13298-13309. (Pubitemid 41508144)
105. Evens AM, Schumacker PT, Helenowski IB, Singh AT, Dokic D, et al. (2008) Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family. Br J Haematol 141: 676-680. (Pubitemid 351667626)
106. Aiyar A, Sugden B (1998) Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins. J Biol Chem 273: 33073-33081. (Pubitemid 28557704)
107. Ustav E, Ustav M, Szymanski P, Stenlund A (1993) The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc Natl Acad Sci U S A 90: 898-902. (Pubitemid 23971195)
108. Frisan T, Levitsky V, Masucci M (2001) Generation of Lymphoblastoid Cell Lines (LCLs). In: Wilson JB, May GHW, eds. Epstein-Barr Virus Protocols. Totowa, NJ: Humana Press. pp 125-127.
109. Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB (2006) Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-mycexpressing Burkitt lymphoma cells. Proc Natl Acad Sci U S A 103: 14935-14940.